Edition:
United Kingdom

Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

3.43USD
20 Jul 2018
Change (% chg)

$-0.05 (-1.44%)
Prev Close
$3.48
Open
$3.45
Day's High
$3.46
Day's Low
$3.13
Volume
1,542,450
Avg. Vol
1,397,291
52-wk High
$6.68
52-wk Low
$1.75

Chart for

About

Geron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company is engaged in the development of therapeutic products for oncology. Using its nucleic acid chemistry,... (more)

Overall

Beta: 2.64
Market Cap(Mil.): $366.19
Shares Outstanding(Mil.): 159.21
Dividend: --
Yield (%): --

Financials

  GERN.OQ Industry Sector
P/E (TTM): -- 85.33 32.76
EPS (TTM): -0.16 -- --
ROI: -21.08 2.22 14.61
ROE: -21.08 3.86 16.34

BRIEF-Geron Corporation Reports Q4 Loss Per Share $0.05

* ORATION REPORTS FOURTH QUARTER AND ANNUAL 2017 FINANCIAL RESULTS AND RECENT EVENTS

16 Mar 2018

Earnings vs. Estimates